E-40 | Demographic Features and Cost Analysis of Patients Undergoing Percutaneous Pulmonary Valve Implantation (PPVI), an Insight from the National Inpatient Sample (NIS) Database

Abstract

BackgroundPercutaneous Pulmonary Valve Implantation (PPVI) was initially developed as an alternative to surgical management in patients with Right Ventricular Outflow Tract (RVOT) dysfunction, including stenosis or regurgitation. We present the first ever demographic analysis of patients from the National Inpatient Sample Database (NIS), undergoing PPVI including supplementation, repair or revision of stenotic valve conduits.MethodsNIS CORE datasets from 2012–2017 were used to extrapolate data for patients undergoing above procedures. Data was analyzed using SAS Analytics.ResultsOf the 37,559,346 cases recorded between 2012 to 2017, 463 met the inclusion criteria, including 291(62.9%) males and 172 (37.2%) females. Majority of the patients were white (60.1%), however, Hispanics were disproportionately represented as compared to their demographic distribution. The most common co-morbidities were diabetes (5.2%) and pulmonary diseases (5.8%). The mean age at admission was 24.9 years with an average length of stay of 3 days. Co-existing valvular disorders were present in only less than 10 cases. Mortality was also low, <=10 cases. Mean cost of inpatient stay was 53,794$ with a maximum of 456,788$. Data is illustrated in Table 1 and Table 2.ConclusionsDisclosuresM. S. Khan Nothing to disclose. A. Baqi Nothing to disclose. M. Al-Dabbas Nothing to disclose. J. Shah Nothing to disclose. W. Ullah Nothing to disclose. A. Khan Nothing to disclose. T. Mir Nothing to disclose. M. Z. Khan Nothing to disclose. F. Salman Nothing to disclose. K. H. Changal Nothing to disclose. M. Ahsan Nothing to disclose. S. S. Ali Nothing to disclose. H. Singh Nothing to disclose. BackgroundPercutaneous Pulmonary Valve Implantation (PPVI) was initially developed as an alternative to surgical management in patients with Right Ventricular Outflow Tract (RVOT) dysfunction, including stenosis or regurgitation. We present the first ever demographic analysis of patients from the National Inpatient Sample Database (NIS), undergoing PPVI including supplementation, repair or revision of stenotic valve conduits. Percutaneous Pulmonary Valve Implantation (PPVI) was initially developed as an alternative to surgical management in patients with Right Ventricular Outflow Tract (RVOT) dysfunction, including stenosis or regurgitation. We present the first ever demographic analysis of patients from the National Inpatient Sample Database (NIS), undergoing PPVI including supplementation, repair or revision of stenotic valve conduits. MethodsNIS CORE datasets from 2012–2017 were used to extrapolate data for patients undergoing above procedures. Data was analyzed using SAS Analytics. NIS CORE datasets from 2012–2017 were used to extrapolate data for patients undergoing above procedures. Data was analyzed using SAS Analytics. ResultsOf the 37,559,346 cases recorded between 2012 to 2017, 463 met the inclusion criteria, including 291(62.9%) males and 172 (37.2%) females. Majority of the patients were white (60.1%), however, Hispanics were disproportionately represented as compared to their demographic distribution. The most common co-morbidities were diabetes (5.2%) and pulmonary diseases (5.8%). The mean age at admission was 24.9 years with an average length of stay of 3 days. Co-existing valvular disorders were present in only less than 10 cases. Mortality was also low, <=10 cases. Mean cost of inpatient stay was 53,794$ with a maximum of 456,788$. Data is illustrated in Table 1 and Table 2. Of the 37,559,346 cases recorded between 2012 to 2017, 463 met the inclusion criteria, including 291(62.9%) males and 172 (37.2%) females. Majority of the patients were white (60.1%), however, Hispanics were disproportionately represented as compared to their demographic distribution. The most common co-morbidities were diabetes (5.2%) and pulmonary diseases (5.8%). The mean age at admission was 24.9 years with an average length of stay of 3 days. Co-existing valvular disorders were present in only less than 10 cases. Mortality was also low, <=10 cases. Mean cost of inpatient stay was 53,794$ with a maximum of 456,788$. Data is illustrated in Table 1 and Table 2. Conclusions DisclosuresM. S. Khan Nothing to disclose. A. Baqi Nothing to disclose. M. Al-Dabbas Nothing to disclose. J. Shah Nothing to disclose. W. Ullah Nothing to disclose. A. Khan Nothing to disclose. T. Mir Nothing to disclose. M. Z. Khan Nothing to disclose. F. Salman Nothing to disclose. K. H. Changal Nothing to disclose. M. Ahsan Nothing to disclose. S. S. Ali Nothing to disclose. H. Singh Nothing to disclose. M. S. Khan Nothing to disclose. A. Baqi Nothing to disclose. M. Al-Dabbas Nothing to disclose. J. Shah Nothing to disclose. W. Ullah Nothing to disclose. A. Khan Nothing to disclose. T. Mir Nothing to disclose. M. Z. Khan Nothing to disclose. F. Salman Nothing to disclose. K. H. Changal Nothing to disclose. M. Ahsan Nothing to disclose. S. S. Ali Nothing to disclose. H. Singh Nothing to disclose.